American Century Companies’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-197,704	Closed	-$326K	–	2908
2024 Q4	$326K	Buy	197,704 +12,295	+7%	+$31K	﹤0.01%	2655
2024 Q3	$649K	Buy	185,409 +19,154	+12%	+$74.5K	﹤0.01%	2382
2024 Q2	$545K	Buy	166,255 +34,676	+26%	+$152K	﹤0.01%	2410
2024 Q1	$966K	Buy	131,579 +78,597	+148%	+$486K	﹤0.01%	2164
2023 Q4	$198K	Buy	52,982 +15,920	+43%	+$37.6K	﹤0.01%	2696
2023 Q3	$78.6K	Buy	37,062 +15,848	+75%	+$52.5K	﹤0.01%	2754
2023 Q2	$101K	Buy	+21,214	New	+$117K	﹤0.01%	2675
2023 Q1	–	Sell	-327,880	Closed	-$3.31M	–	2677
2022 Q4	$3.31M	Buy	327,880 +90,990	+38%	+$1.71M	﹤0.01%	1384
2022 Q3	$5.31M	Buy	236,890 +1,655	+0.7%	+$47.8K	﹤0.01%	1086
2022 Q2	$5.83M	Buy	235,235 +18,560	+9%	+$512K	﹤0.01%	1078
2022 Q1	$8.4M	Buy	216,675 +37,090	+21%	+$1.44M	0.01%	959
2021 Q4	$10.5M	Buy	179,585 +42,141	+31%	+$2.39M	0.01%	863
2021 Q3	$8.15M	Buy	137,444 +7,290	+6%	+$572K	0.01%	902
2021 Q2	$11.3M	Buy	130,154 +332	+0.3%	+$26.8K	0.01%	786
2021 Q1	$10.7M	Buy	129,822 +117,395	+945%	+$11.2M	0.01%	765
2020 Q4	$1.13M	Buy	+12,427	New	+$772K	﹤0.01%	1225